Songul Sonal

Songul Sonal

Auto-generated profile, based on publicly available information

Songul Sonal

Uludag University

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 December 2019 in Journal of Research in Veterinary Medicine
Verified
Journal Article
Open access
PDF file
EBEsra Buyukcangaz
Esra Buyukcangaz
MKMohammed Khi̇dEr
Mohammed Khi̇dEr
AŞAyşin ŞEN
Ayşin ŞEN
MCMurat Cengi̇z
Murat Cengi̇z
SSSongül Sonal
Songül Sonal
This research investigated the presence of virulence genes encoding F41, K99, eae, Stx1, Stx2 and STa and the antimicrobial resistance of animal Escherichia coli (E. coli) isolates. Clinical isolates (n:233) were evaluated from faecal samples of cattle, sheep, goats, horses, cats and dogs collected between the years of 2010 to 2015 from Turkey. Enterohaemorrahic E.coli (EHEC) O157:H7 was detected by using cefixime tellurite sorbitol MacConkey agar (CT-SMAC) and Wellcollex E. coli (Remel®). The Kirby-Bauer disc diffusion test was performed to detect the resistance pattern of the isolates to ampicillin, Amoxycillin/clavulanic acid, enrofloxacin, ceftiofur, trimethoprim/sulfamethoxazole and tetracycline. The results showed that 40% of the ruminant isolates were identified as Shiga-toxin producing Escherichia coli (STEC). Enterotoxigenic E. coli (ETEC) was detected in samples from cattle (0.9%) and sheep (12%). Enteropathogenic E.coli (EPEC) was detected in samples from cattle (0.9%) and dogs (11.4%). EHEC O157:H7 was not detected any of the isolates. Among all E. coli isolates that carried at least one virulence gene, 8 (19%) were resistant to more than three antimicrobials, 7 (16.7%) were resistant to at least one antimicrobial and 27 (64.3%) were susceptible to all antimicrobials.

18 December 2019 in Journal of Research in Veterinary Medicine
Verified
Journal Article
Closed access
PDF file
MCMurat Cengi̇z
Murat Cengi̇z
PSPinar Sahi̇nturk
Pinar Sahi̇nturk
GHGulce Hepbostanci̇
Gulce Hepbostanci̇
EAEMİN HALİS Akalin
EMİN HALİS Akalin
SSSongul Sonal
Songul Sonal
As an alternative antimicrobial combination, danofloxacin+colistin was used for the inhibition of multidrug resistant E. coli. After evaluation of interaction between the drugs by fractional inhibitory concentration tests and time kill assays, antimicrobial activity of the combination was showed by in vitro pharmacodynamics tests (minimum bactericidal concentration and mutant prevention concentration). Post-antibiotic and post-antibiotic sub-MIC effects were also determined in this study. In synergism tests, danofloxacin+colistin was found highly synergistic (%87) against E. coliisolates from animal origin. The combination exerted bactericidal activity against all E. coliisolates and individual bactericidal activity of each compound was lower than the combination. The combination reduced mutant prevention concentration of danofloxacin and colistin up to 32 –fold. Post-antibiotic sub-MIC effects of the combination at all sub-MIC concentrations were significantly longer than the post-antibiotic effects of combination (p < 0.001), danofloxacin (p < 0.001) and colistin (p < 0.001). The results of this study showed that danofloxacin+colistin combination can be reserved as an alternative drug combination against MDR E. coliin veterinary medicine.